Pomanda estimates the enterprise value of SHIRE PHARMACEUTICALS SERVICES LIMITED at £814.7k based on a Turnover of £681k and 1.2x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of SHIRE PHARMACEUTICALS SERVICES LIMITED at £307.2k based on an EBITDA of £39k and a 7.88x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of SHIRE PHARMACEUTICALS SERVICES LIMITED at £10.8m based on Net Assets of £5.5m and 1.96x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Shire Pharmaceuticals Services LimitedOverview
Shire Pharmaceuticals Services Limited is a dissolved company that was located in london, W2 6BD with a Companies House number of 04420273. It operated in the other service activities n.e.c. sector, SIC Code 96090. Founded in April 2002, it's largest shareholder was
shire pharmaceuticals group
with a 100% stake. The last turnover for Shire Pharmaceuticals Services Limited was estimated at £681k.
Shire Pharmaceuticals Services Limited Health Check
Pomanda's financial health check has awarded Shire Pharmaceuticals Services Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
Health Rating3.5out of 5
3 Strong
1 Regular
5 Weak
Size
annual sales of £681k, make it smaller than the average company (£928.6k)
£681k - Shire Pharmaceuticals Services Limited
£928.6k - Industry AVG
Growth
3 year (CAGR) sales growth of -38%, show it is growing at a slower rate (2.8%)
-38% - Shire Pharmaceuticals Services Limited
2.8% - Industry AVG
Production
with a gross margin of 100%, this company has a lower cost of product (39.5%)
100% - Shire Pharmaceuticals Services Limited
39.5% - Industry AVG
Profitability
an operating margin of 5.7% make it as profitable than the average company (5.3%)
5.7% - Shire Pharmaceuticals Services Limited
5.3% - Industry AVG
Employees
with 4 employees, this is below the industry average (15)
4 - Shire Pharmaceuticals Services Limited
15 - Industry AVG
Pay Structure
on an average salary of £104k, the company has a higher pay structure (£29.7k)
£104k - Shire Pharmaceuticals Services Limited
£29.7k - Industry AVG
Efficiency
resulting in sales per employee of £170.3k, this is more efficient (£82.7k)
£170.3k - Shire Pharmaceuticals Services Limited
£82.7k - Industry AVG
Debtor Days
it gets paid by customers after 3976 days, this is later than average (31 days)
3976 days - Shire Pharmaceuticals Services Limited
31 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Shire Pharmaceuticals Services Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Shire Pharmaceuticals Services Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Shire Pharmaceuticals Services Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 25.6%, this is a lower level of debt than the average (50.9%)
25.6% - Shire Pharmaceuticals Services Limited
50.9% - Industry AVG
SHIRE PHARMACEUTICALS SERVICES LIMITED financials
EXPORT
Shire Pharmaceuticals Services Limited's latest turnover from December 2020 is £681 thousand and the company has net assets of £5.5 million. According to their latest financial statements, Shire Pharmaceuticals Services Limited has 4 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Turnover
681,000
655,000
2,087,000
2,904,000
9,812,000
6,313,000
4,902,000
5,958,000
6,929,000
11,752,000
19,259,000
13,259,000
Other Income Or Grants
Cost Of Sales
1,265,494
1,747,528
5,790,134
3,731,144
2,928,962
3,480,944
3,970,882
6,704,527
10,756,298
Gross Profit
681,000
655,000
821,506
1,156,472
4,021,866
2,581,856
1,973,038
2,477,056
2,958,118
5,047,473
8,502,702
Admin Expenses
642,000
705,000
899,506
1,428,472
3,830,616
2,806,856
2,299,038
2,620,056
2,835,118
798,473
9,975,702
249,000
Operating Profit
39,000
-50,000
-78,000
-272,000
191,250
-225,000
-326,000
-143,000
123,000
4,249,000
-1,473,000
-249,000
Interest Payable
4,000
33,000
33,000
21,000
Interest Receivable
28,000
15,000
5,000
3,000
Pre-Tax Profit
67,000
-35,000
-73,000
-272,000
182,000
-213,000
-326,000
-143,000
119,000
4,216,000
-1,506,000
-267,000
Tax
-21,000
-42,000
-59,000
16,000
-29,000
-12,000
55,000
-70,000
-197,000
7,000
271,000
6,000
Profit After Tax
46,000
-77,000
-132,000
-256,000
153,000
-225,000
-271,000
-213,000
-78,000
4,223,000
-1,235,000
-261,000
Dividends Paid
Retained Profit
46,000
-77,000
-132,000
-256,000
153,000
-225,000
-271,000
-213,000
-78,000
4,223,000
-1,235,000
-261,000
Employee Costs
416,000
494,000
1,290,000
1,901,000
6,603,000
3,971,000
3,475,000
4,270,000
3,708,000
4,504,000
7,256,000
5,039,000
Number Of Employees
4
4
8
20
42
37
37
37
38
35
48
48
EBITDA*
39,000
-50,000
-78,000
-272,000
191,250
-225,000
-326,000
-143,000
123,000
4,249,000
-1,473,000
-249,000
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Tangible Assets
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
9,000
51,000
110,000
94,000
123,000
135,000
79,000
149,000
346,000
339,000
68,000
Total Fixed Assets
9,000
51,000
110,000
94,000
123,000
135,000
79,000
149,000
346,000
339,000
68,000
Stock & work in progress
Trade Debtors
7,419,000
Group Debtors
8,312,000
8,564,000
7,781,000
12,239,000
8,296,000
8,068,000
10,703,000
12,205,000
11,731,000
5,228,000
4,902,000
Misc Debtors
39,000
10,000
50,000
236,000
43,000
110,000
55,000
30,000
25,000
705,000
122,000
Cash
1,000
misc current assets
total current assets
7,419,000
8,351,000
8,574,000
7,831,000
12,475,000
8,339,000
8,178,000
10,758,000
12,235,000
11,756,000
5,933,000
5,025,000
total assets
7,419,000
8,360,000
8,625,000
7,941,000
12,569,000
8,462,000
8,313,000
10,837,000
12,384,000
12,102,000
6,272,000
5,093,000
Bank overdraft
Bank loan
Trade Creditors
1,901,000
36,000
97,000
45,000
438,000
344,000
403,000
288,000
114,000
34,000
502,000
71,000
Group/Directors Accounts
1,803,000
1,158,000
554,000
2,055,000
1,198,000
1,425,000
2,866,000
5,610,000
3,841,000
63,000
474,000
other short term finances
hp & lease commitments
other current liabilities
1,046,000
1,878,000
1,823,000
4,621,000
1,842,000
1,453,000
2,784,000
1,812,000
3,396,000
5,730,000
4,131,000
total current liabilities
1,901,000
2,885,000
3,133,000
2,422,000
7,114,000
3,384,000
3,281,000
5,938,000
7,536,000
7,271,000
6,295,000
4,676,000
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
4,000
19,000
51,000
121,000
144,000
119,000
138,000
303,000
260,000
198,000
total long term liabilities
4,000
19,000
51,000
121,000
144,000
119,000
138,000
303,000
260,000
198,000
total liabilities
1,901,000
2,885,000
3,137,000
2,441,000
7,165,000
3,505,000
3,425,000
6,057,000
7,674,000
7,574,000
6,555,000
4,874,000
net assets
5,518,000
5,475,000
5,488,000
5,500,000
5,404,000
4,957,000
4,888,000
4,780,000
4,710,000
4,528,000
-283,000
219,000
total shareholders funds
5,518,000
5,475,000
5,488,000
5,500,000
5,404,000
4,957,000
4,888,000
4,780,000
4,710,000
4,528,000
-283,000
219,000
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Operating Activities
Operating Profit
39,000
-50,000
-78,000
-272,000
191,250
-225,000
-326,000
-143,000
123,000
4,249,000
-1,473,000
-249,000
Depreciation
Amortisation
Tax
-21,000
-42,000
-59,000
16,000
-29,000
-12,000
55,000
-70,000
-197,000
7,000
271,000
6,000
Stock
Debtors
-941,000
-265,000
684,000
-4,628,000
4,107,000
149,000
-2,524,000
-1,547,000
282,000
5,830,000
1,180,000
5,092,000
Creditors
1,865,000
-61,000
52,000
-393,000
94,000
-59,000
115,000
174,000
80,000
-468,000
431,000
71,000
Accruals and Deferred Income
-1,046,000
-832,000
55,000
-2,798,000
2,779,000
389,000
-1,331,000
972,000
-1,584,000
-2,334,000
1,599,000
4,131,000
Deferred Taxes & Provisions
-4,000
-15,000
-32,000
-70,000
-23,000
25,000
-19,000
-165,000
43,000
62,000
198,000
Cash flow from operations
1,778,000
-724,000
-729,000
1,149,000
-1,141,750
-79,000
1,062,000
2,461,000
-2,025,000
-4,333,000
-290,000
-935,000
Investing Activities
capital expenditure
Change in Investments
cash flow from investments
Financing Activities
Bank loans
Group/Directors Accounts
-1,803,000
645,000
604,000
-1,501,000
857,000
-227,000
-1,441,000
-2,744,000
1,769,000
3,778,000
-411,000
474,000
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
-3,000
64,000
120,000
352,000
294,000
294,000
379,000
283,000
260,000
588,000
733,000
480,000
interest
28,000
15,000
5,000
-4,000
-33,000
-33,000
-18,000
cash flow from financing
-1,778,000
724,000
729,000
-1,149,000
1,151,000
67,000
-1,062,000
-2,461,000
2,025,000
4,333,000
289,000
936,000
cash and cash equivalents
cash
-1,000
1,000
overdraft
change in cash
-1,000
1,000
shire pharmaceuticals services limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for shire pharmaceuticals services limited. Get real-time insights into shire pharmaceuticals services limited's credit score, group structure and payment trends.
Perform a competitor analysis for shire pharmaceuticals services limited by selecting its closest rivals, whether from the OTHER SERVICE ACTIVITIES sector, other undefined companies, companies in W 2 area or any other competitors across 12 key performance metrics.
shire pharmaceuticals services limited Ownership
SHIRE PHARMACEUTICALS SERVICES LIMITED group structure
Shire Pharmaceuticals Services Limited has no subsidiary companies.
The sole shareholder of Shire Pharmaceuticals Services Limited is Shire Pharmaceuticals Group.
shire pharmaceuticals group
100%
shire pharmaceuticals services limited directors
Shire Pharmaceuticals Services Limited currently has 3 directors.
The longest serving directors include
Mr Marc Page (Nov 2020) and
Mr Kentaro Shirahata (Nov 2020).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to shire pharmaceuticals services limited.
shire pharmaceuticals services limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for SHIRE PHARMACEUTICALS SERVICES LIMITED. This can take several minutes, an email will notify you when this has completed.
shire pharmaceuticals services limitedCompanies House Filings - See Documents
